Hypothesis

3 Matching Annotations

Feb 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapy

1
1. scibot 24 Feb 2026
  
  in Public
  
  RRID:AB_2228868
  
  DOI: 10.1016/j.xcrm.2025.102568
  
  Resource: (BioLegend Cat# 329711, RRID:AB_2228868)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2228868
  
  What is this?
  
  RRID:AB_2228868
Visit annotations in context

Tags

RRID:AB_2228868

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12923962/
Feb 2023
www.sciencedirect.com www.sciencedirect.com

Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria

1
1. scibot 03 Feb 2023
  
  in Public
  
  RRID:AB_2228868
  
  DOI: 10.1016/j.cell.2022.12.038
  
  Resource: (BioLegend Cat# 329711, RRID:AB_2228868)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2228868
  
  What is this?
  
  RRID:AB_2228868
Visit annotations in context

Tags

RRID:AB_2228868

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867422015811
Mar 2022
www.sciencedirect.com www.sciencedirect.com

Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma

1
1. scibot 04 Mar 2022
  
  in Public
  
  RRID:AB_2228868
  
  DOI: 10.1016/j.ymthe.2022.02.005
  
  Resource: (BioLegend Cat# 329711, RRID:AB_2228868)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2228868
  
  What is this?
  
  RRID:AB_2228868
Visit annotations in context

Tags

RRID:AB_2228868

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1525001622000880